peter attia glp-1 Could GLP-1s impact aging and cognitive health? Does Peter Attia's Longevity Plan
Description
(This prevents creating a vacuum and makes insulin withdrawal easier.)
reducing reliance on costly imports." Key findings: With 98 GLP-1 drugs in trials, patent expiry in 2026 enabling biosimilars, and a projected $150B market by 2035, China could challenge Western dominancedespite regulatory hurdles and US tariffs
Side effects - 'short term' side effect profiles or these two drugs are different but do not suggest a clear differentiator
Read the article for insights.
Metabolism Boost
